Literature DB >> 3074288

The changing face of chemotherapy.

W Brumfitt1, J M Hamilton-Miller.   

Abstract

The historical development of antibiotics has been summarized. Three distinct phases are discernible. The first (from historical times to about 1900) involved mostly folk remedies. The second (1900-c. 1940) was ushered in by Paul Ehrlich's development of the concept of 'selective toxicity' and saw the establishment of arsenicals and sulphonamides. The third, lasting to the present day, started with the exploitation of the pioneering studies of Fleming, Dubos and Waksman on antibiotic production by soil fungi. This latest phase has continued with the improvement of natural products by the skills of the medicinal chemist. The properties and evolution of three major groups of antibiotics, penicillins, cephalosporins and aminoglycosides are fully described. Finally, pathways of possible future evolution of antibiotics are outlined.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3074288      PMCID: PMC2428900          DOI: 10.1136/pgmj.64.753.552

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  4 in total

1.  Benign streptococcal sore throat.

Authors:  W BRUMFITT; F O'GRADY; J D SLATER
Journal:  Lancet       Date:  1959-09-26       Impact factor: 79.321

2.  6-APA and the development of the beta-lactam antibiotics.

Authors:  G N Rolinson
Journal:  J Antimicrob Chemother       Date:  1979-01       Impact factor: 5.790

3.  The use of rifampin in the treatment of nontuberculous infections: an overview.

Authors:  M A Sande
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

Review 4.  The tetracyclines: prospects at the beginning of the 1980s.

Authors:  I Chopra; T G Howe; A H Linton; K B Linton; M H Richmond; D C Speller
Journal:  J Antimicrob Chemother       Date:  1981-07       Impact factor: 5.790

  4 in total
  2 in total

1.  [Use of antibacterial chemotherapy. A historical comparison].

Authors:  K H Spitzy
Journal:  Infection       Date:  1991       Impact factor: 3.553

2.  Prediction of clinically relevant safety signals of nephrotoxicity through plasma metabolite profiling.

Authors:  W B Mattes; H G Kamp; E Fabian; M Herold; G Krennrich; R Looser; W Mellert; A Prokoudine; V Strauss; B van Ravenzwaay; T Walk; H Naraoka; K Omura; I Schuppe-Koistinen; S Nadanaciva; E D Bush; N Moeller; P Ruiz-Noppinger; S P Piccoli
Journal:  Biomed Res Int       Date:  2013-05-21       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.